Imagion Biosystems Limited
Imagion Biosystems Limited provides medical imaging technologies using magnetic resonance. It is involved in the nanotechnology; biotechnology; and cancer diagnostics businesses. The company develops MagSense, which completed Phase 1 for the treatment of HER2 breast cancers, as well as advancing the research and development programs for prostate and ovarian cancer. It also develops PrecisionMRX, … Read more
Imagion Biosystems Limited (IBXXF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.460x
Based on the latest financial reports, Imagion Biosystems Limited (IBXXF) has a cash flow conversion efficiency ratio of 0.460x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.78 Million) by net assets ($-3.87 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Imagion Biosystems Limited - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Imagion Biosystems Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Imagion Biosystems Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Imagion Biosystems Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PNC FINL SER
BE:PNP
|
0.059x |
|
Oriental Trimex Limited
NSE:ORIENTALTL
|
0.008x |
|
Tasman Resources Ltd
PINK:TASEF
|
-0.823x |
|
ELECTRONIC ARTS - Dusseldorf Stock Exchang
DU:ERT
|
0.032x |
|
VERISK ANLYTCS-A
BE:VA7A
|
0.972x |
|
Taoping Inc
NASDAQ:TAOP
|
-0.051x |
|
M&T BANK - Dusseldorf Stock Exchang
DU:MTZ
|
-0.001x |
|
Citra Nusa Holdings Bhd
KLSE:5104
|
0.009x |
Annual Cash Flow Conversion Efficiency for Imagion Biosystems Limited (2014–2024)
The table below shows the annual cash flow conversion efficiency of Imagion Biosystems Limited from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-2.28 Million | $-1.27 Million | 0.557x | -74.65% |
| 2023-12-31 | $-3.79 Million | $-8.32 Million | 2.195x | +227.18% |
| 2022-12-31 | $4.68 Million | $-8.07 Million | -1.726x | -353.14% |
| 2021-12-31 | $13.31 Million | $-5.07 Million | -0.381x | -6.41% |
| 2020-12-31 | $12.91 Million | $-4.62 Million | -0.358x | +74.55% |
| 2019-12-31 | $2.97 Million | $-4.18 Million | -1.406x | +33.10% |
| 2018-12-31 | $3.87 Million | $-8.13 Million | -2.102x | -109.47% |
| 2017-12-31 | $6.95 Million | $-6.98 Million | -1.004x | -4289.57% |
| 2016-12-31 | $11.69 Million | $-267.26K | -0.023x | -104.80% |
| 2015-12-31 | $-8.86 Million | $-4.22 Million | 0.477x | -22.14% |
| 2014-12-31 | $-3.97 Million | $-2.43 Million | 0.612x | -- |